Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

NCT03700112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-06-14

No results posted yet for this study

Summary

A Randomized Study Comparing Nicotine Pharmacokinetics of Seven Electronic Cigarette Products and One Traditional Cigarette Across Two Delivery (10 puff and ad- libitum) Conditions, in Healthy Adult Smokers

Conditions

  • Nicotine Dependence
  • Nicotine Dependence, Cigarettes
  • Tobacco Use
  • Tobacco Smoking

Interventions

OTHER

JUUL Virginia Tobacco flavored 5.0% ENDS

Virginia Tobacco Flavored 5.0% ENDS product is administered using a controlled method and adlibitum

OTHER

PMI iQOS Heat sticks

PMI IQOS Heat sticks is administered using a controlled method and ad-libitum

OTHER

Reynolds VUSE Solo ENDS - Original

Reynolds VUSE solo ENDS - Original is administered using a controlled method and ad-libitum

OTHER

Imperial MyBlu ENDS - Original

Imperial MyBlu ENDS- original is administered using a controlled method and ad-libitum

OTHER

Altria MarkTen ENDS - Bold Classic

Altria MarkTen ENDS - Bold Classic is administered using a controlled method and ad-libitum

OTHER

MLV PHIX ENDS - Original Tobacco

MLV PHIX ENDS - Original Tobacco is administered using a controlled method and ad-libitum

OTHER

NJOY Daily EXTRA ENDS - Rich Tobacco

NJOY Daily EXTRA ENDS - Rich Tobacco is administered using a controlled method and ad-libitum

OTHER

Altria Marlboro combustible cigarette - Red

Altria Marlboro combustible cigarette - Red is administered using a controlled method and ad-libitum

Sponsors & Collaborators

  • Juul Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Concetta Carbonaro · JUUL

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-04
Primary Completion
2019-02-24
Completion
2019-04-09

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03700112 on ClinicalTrials.gov